For the third time this year, IP Australia has upheld a challenge to a coffee capsule patent, finding that the patent, owned by a unit of German food giant Kruger, was not inventive.
Two generic drug makers are fighting for access to confidential documents related to amendments by Neurim Pharmaceutical of patents covering its sleep drug Circadin, telling the Federal Court on Thursday privilege had been waived after a phone conversation between the company’s founder and her lawyers from DLA Piper.
Drug giant F. Hoffman-La Roche asked the Federal Court Tuesday for an order barring the release of a generic version of its blockbuster cancer drug MabThera by a unit of Swiss rival Novartis, which it claims could lead to “tens of millions of dollars” in losses.
SNF has filed an appeal with the Federal Court after the Australian Patent Office shot down its challenge to a mining patent application by rival BASF.
Take-Two Interactive has won a temporary injunction blocking a gamer from making unauthorised changes to its popular Grand Theft Auto video game.
Telecom giant Optus has come up short in a Federal Court challenge to trademark registration for health services company Optum, with a judge saying the two company’s marks — despite the difference of just one letter — were distinct enough.
A full bench of the Federal Court has dismissed an appeal by drug giant GlaxoSmithKline in a patent infringement case it brought over planned generic versions of its sustained-release Panadol.
A Federal Court judge has permanently barred a woman who claims she owns the intellectual property for an Infa-Secure seat belt device from telling retailers that she is the rightful owner of the device’s IP.
An appeal has been filed by financial software company Encompass Corp. after a Federal Court judge found two of its patents for computer software failed the method of manufacture test and were invalid.
Taronga Conservation Society Australia and Sydney Zoo have agreed to settle their legal battle over the use of the name “Sydney Zoo”.